mergers & acquisitions
Hong Kong-Based Prenetics to go Public via SPAC
The company recently launched a point-of-care and at-home rapid health monitoring system for infectious diseases.
Ginkgo Bioworks to Go Public With $1.63B in Proceeds From SPAC Merger
The company originally announced its intention to go public through the merger with Soaring Eagle in May and will begin trading on the NYSE on Friday.
Mesa Laboratories Acquires Agena Bioscience for $300M
Agena is expected to add between $63 million and $67 million to Mesa's revenues during the first year of ownership, excluding COVID-related revenues.
Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio
TIB Molbiol already has more than 45 CE-marked tests available on Roche's LightCycle PCR instruments and its MagNA Pure sample prep systems.
Spartan Bioscience to Sell Assets to Finance Firm Casa-Dea
Casa-Dea said that it aims to keep Spartan in Canada following the close of the transaction, which is expected later this month.
Aug 25, 2021
AccessDx Acquires 2bPrecise From Allscripts
Aug 12, 2021
PerkinElmer Enters $500M Credit Facility
Jul 26, 2021
PathAI Acquires Poplar Healthcare Management
Jul 9, 2021
Jul 6, 2021
ACT Genomics Acquires MC Diagnostics
Jul 1, 2021
Telehealth Firm Ro Acquires At-Home Testing Firm
Jun 30, 2021